For breast cancer, the most common screening method - mammography - is alarmingly inaccurate. The New England Journal of Medicine estimates 31% of all breast cancer cases may be misdiagnosed.
Approximately 39 million mammography’s are preformed each year in the USA.
Thousands of women are being misdiagnosed.
This needs to change.
With a simple blood draw BreastDefense aims to distinguish benign and malignant tissue with 99% accuracy.